Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series

Detalles Bibliográficos
Autores principales: MARESCHAL, Adrien, PUZENAT, Eve, AUBIN, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128934/
https://www.ncbi.nlm.nih.gov/pubmed/31709451
http://dx.doi.org/10.2340/00015555-3368
_version_ 1784712651072339968
author MARESCHAL, Adrien
PUZENAT, Eve
AUBIN, François
author_facet MARESCHAL, Adrien
PUZENAT, Eve
AUBIN, François
author_sort MARESCHAL, Adrien
collection PubMed
description
format Online
Article
Text
id pubmed-9128934
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Society for Publication of Acta Dermato-Venereologica
record_format MEDLINE/PubMed
spelling pubmed-91289342022-10-20 Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series MARESCHAL, Adrien PUZENAT, Eve AUBIN, François Acta Derm Venereol Short Communication Society for Publication of Acta Dermato-Venereologica 2020-01-07 /pmc/articles/PMC9128934/ /pubmed/31709451 http://dx.doi.org/10.2340/00015555-3368 Text en © 2020 Acta Dermato-Venereologica https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the CC BY-NC license
spellingShingle Short Communication
MARESCHAL, Adrien
PUZENAT, Eve
AUBIN, François
Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
title Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
title_full Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
title_fullStr Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
title_full_unstemmed Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
title_short Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
title_sort dupilumab efficacy and safety in adolescents with moderate-to-severe atopic dermatitis: a case series
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128934/
https://www.ncbi.nlm.nih.gov/pubmed/31709451
http://dx.doi.org/10.2340/00015555-3368
work_keys_str_mv AT mareschaladrien dupilumabefficacyandsafetyinadolescentswithmoderatetosevereatopicdermatitisacaseseries
AT puzenateve dupilumabefficacyandsafetyinadolescentswithmoderatetosevereatopicdermatitisacaseseries
AT aubinfrancois dupilumabefficacyandsafetyinadolescentswithmoderatetosevereatopicdermatitisacaseseries

Ejemplares similares